Mean Weight Loss in Pivotal Trials Maximum Dose, ITT Population Tirzepatide 15 mg weekly SURMOUNT-1, NEJM 2022 n=2,539 PMID 35658024 22.5% body weight 72 weeks Tirzepatide 10 mg weekly SURMOUNT-1, NEJM 2022 19.5% body weight 72 weeks Tirzepatide vs Semaglutide head-to-head SURPASS-2, NEJM 2021 n=1,879 +47% more weight loss vs sema Semaglutide 2.4 mg weekly (comparison) STEP-1, NEJM 2021 14.9% body weight 68 weeks Frequently Asked Questions Common questions about NexLife and tirzepatide Is NexLife legit for tirzepatide
S., Lani, M
Add your BAC water volume Typical reconstitution uses 13 mL of bacteriostatic water
Some patients value a hands-on approach while others want minimal in-person visits
See the complete Peptides & GLP-1 collection
Semaglutide is also available under the brand name Wegovy , which is FDA-approved for people with obesity and people with overweight who have a weight-related health condition, such as high blood pressure or type 2 diabetes